A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD
Clinical trial NCT00056264 · COMPLETED
Trial details
- NCT number
- NCT00056264
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.